Delisting risk
Addex Therapeutics (ADR) (ADXN)
Develops allosteric CNS drug candidates through internal programs, partnerships, and investments.
$3.78
Pre-market+0.23 (+6.61%)
At close$3.55(−2.74%)
Something off on this page? Send us feedback.
Next report
Nov 9, 2026
in 67 days
EPS estimate
—
Revenue estimate
—
Fiscal quarter
Q2 FY26
EPSReportedEstimate
Sep '24Nov '24Apr '25Jun '25Dec '25Apr '26Jun '26Nov '26
Reported−$1.77−$2.77−$1.63−$1.33−$1.50−$1.94−$1.53Pending
Estimate−$0.01−$1.40−$1.42−$4.26—−$1.42——
Surprise−17,600.0%−97.9%−14.7%+68.8%—−36.0%——
RevenueReportedEstimate
Sep '24Nov '24Apr '25Jun '25Dec '25Apr '26Jun '26Nov '26
Reported$128.7K$62.7K$1.7K—$37.4K$313.0K$9.9KPending
Estimate$260.0K$150.0K$150.0K$236.6K$236.6K$236.6K——
Surprise−50.5%−58.2%−98.9%—−84.2%+32.3%——
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | — | — | — |
| Aug 2026 | — | — | — |
| Jun 2026 | — | −$1.53 | — |
| Jun 2026 | — | — | — |
| Jun 2026 | — | — | — |
| Apr 2026 | −$1.42 | −$1.94 | −36.0% |
| Dec 2025 | — | −$1.50 | — |
| Jun 2025 | −$4.26 | −$1.33 | +68.8% |
The latest year is open to everyone — the 38 quarters behind it read with an account. Sign in | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Sep 2024 | |||
| Jun 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | — | — | — | — | — | — | — |
| Aug 24, 2026 | — | — | — | — | — | — | — |
| Jun 25, 2026 | — | −$1.53 | — | — | $9.9K | — | +2.2% |
| Jun 19, 2026 | — | — | — | — | — | — | — |
| Jun 15, 2026 | — | — | — | — | — | — | — |
| Apr 30, 2026 | −$1.42 | −$1.94 | −36.0% | $236.6K | $313.0K | +32.3% | +0.6% |
| Dec 4, 2025 | — | −$1.50 | — | $236.6K | $37.4K | −84.2% | −7.3% |
| Jun 20, 2025 | −$4.26 | −$1.33 | +68.8% | $236.6K | — | — | −3.0% |
The latest year is open to everyone — the 38 quarters behind it read with an account. Sign in | |||||||
| Apr 7, 2025 | |||||||
| Nov 22, 2024 | |||||||
| Sep 30, 2024 | |||||||
| Jun 6, 2024 | |||||||
| Apr 18, 2024 | |||||||
| Nov 29, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 9, 2023 | |||||||
| Nov 11, 2022 | |||||||
| Aug 18, 2022 | |||||||
| May 5, 2022 | |||||||
| Mar 10, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 5, 2021 | |||||||
| Mar 11, 2021 | |||||||
| Nov 3, 2020 | |||||||
| Aug 12, 2020 | |||||||
| May 20, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 | |||||||